Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Boston Scientific | 46 | 0 | 9 | 0 | €68.50 | €73.05 | 6.638% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 3 | 0 | €69.00 | €79.43 | 15.115% |
| Thermo Fisher Scientific Inc. | 27 | 0 | 3 | 0 | €536.00 | €566.65 | 5.718% |
| CONMED Corp. | 11 | 1 | 3 | 0 | €60.00 | €109.59 | 82.642% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.30 | €421.61 | 16.049% |
| Align Technology | 16 | 2 | 3 | 0 | €288.90 | €345.95 | 19.747% |
| BioMarin Pharmaceutical Inc. | 21 | 0 | 3 | 0 | €75.64 | €102.62 | 35.668% |
| Resmed Inc. | 19 | 0 | 3 | 0 | €203.80 | €207.72 | 1.921% |
| Humana Inc. | 23 | 0 | 3 | 0 | €286.00 | €439.88 | 53.803% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €186.00 | €237.94 | 27.925% |
| Neurocrine Bioscience | 23 | 0 | 2 | 0 | €127.05 | €137.63 | 8.331% |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 2 | 0 | €825.20 | €957.22 | 15.999% |
| Biogen Inc. | 43 | 1 | 2 | 0 | €195.30 | €294.45 | 50.767% |
| Intuitive Surgical Inc | 34 | 0 | 2 | 0 | €350.70 | €370.00 | 5.503% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 2 | 0 | €41.40 | €82.93 | 100.317% |
| XOMA Corp. | 4 | 0 | 1 | 0 | €22.80 | €68.78 | 201.664% |
| Dexcom Inc. | 18 | 0 | 1 | 0 | €116.18 | €136.82 | 17.767% |
| MacroGenics Inc. | 11 | 0 | 1 | 0 | €13.58 | €20.00 | 47.275% |
| Rhythm Pharmaceuticals | 14 | 0 | 1 | 0 | €36.60 | €46.08 | 25.908% |
| Acorda Therapeutics Cdt | 14 | 0 | 1 | 0 | €0.47 | - | - |
| Community Health Systems Inc. | 4 | 3 | 1 | 0 | €3.04 | €5.36 | 76.461% |
| Corcept Therapeutics Inc. | 9 | 0 | 1 | 0 | €21.32 | €33.55 | 57.348% |
| X4 Pharmaceuticals, Inc. | 5 | 0 | 1 | 0 | €1.09 | €2.76 | 153.003% |
| Krystal Biotech | 16 | 0 | 1 | 0 | €145.15 | €173.22 | 19.338% |
| Heron Therapeutics Inc. | 9 | 1 | 1 | 0 | €2.29 | €4.57 | 99.381% |